MSH|^~\&|LAB|ERH|||201912201502||ORU^R01|4133019|D|2.3|||AL|NE
PID|1||ER00001503|ER1503|LABTEST^BEAGLE^||19520202|F||||||||||ER000004/17|
OBR|1|37302^LAB|00028035^2012:C00006R^LAB^201219:C6^37302|522.1690^TESTBIO^Bioavailable Testosterone^^^XXX-0666||201912201502|201912201502|||||||201912201502||||||||||LAB|F||||
OBX|1|ST|522.1700^TESTBIO R^Testost, Bioavailable Result^^X50394^XXX-0666|1|0.50^^Y|nmol/L|0.03-0.32|H||A^S|F|||201912201502
NTE|1||Reference interval applies to postmenopausal females who are
NTE|2||not taking exogenous estrogens. The reference interval for
NTE|3||premenopausal females is 0.04 to 0.38 nmol/L.
NTE|4||NOTE: New Method and Reference Interval